Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
13F holders, Q3 2024
Institutional positions in Cingulate Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- 0 vs. Q2 2024
- Shares held
- 50.0K
- −630.9K (−92.7%) vs. Q2 2024
- Total value
- $251.8K
- +$34.6K (+15.9%) vs. Q2 2024
- New holders
- 6
- 0 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CING on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $9.88M |
| Q1 2026 | 27 | $7.37M |
| Q4 2025 | 18 | $2.23M |
| Q3 2025 | 12 | $1.14M |
| Q2 2025 | 15 | $1.18M |
| Q1 2025 | 9 | $566.1K |
| Q4 2024 | 9 | $447.4K |
| Q3 2024 | 10 | $251.8K |
| Q2 2024 | 10 | $217.1K |
| Q1 2024 | 9 | $128.9K |
| Q4 2023 | 5 | $29.1K |
| Q3 2023 | 20 | $964.5K |
| Q2 2023 | 14 | $400.3K |
| Q1 2023 | 13 | $433.0K |
| Q4 2022 | 11 | $112.1K |
| Q3 2022 | 8 | $283.0K |
| Q2 2022 | 8 | $963.9K |
| Q1 2022 | 6 | $2.13M |
| Q4 2021 | 5 | $3.06M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cingulate Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 21,031 | $106.0K | 0.00% | +21,031 | New |
| UBS Group AG | 13,749 | $69.3K | 0.00% | +13,749 | New |
| Commonwealth Equity Services, LLC | 11,276 | $57.0K | 0.00% | −99,013−89.8% | Reduced |
| Bank of America Corp | 1,878 | $9.46K | 0.00% | −20,624−91.7% | Reduced |
| Tower Research Capital LLC (TRC) | 1,572 | $7.92K | 0.00% | −4,467−74.0% | Reduced |
| FMR LLC | 352 | $1.77K | 0.00% | +352 | New |
| Advisor Group Holdings, Inc. | 55 | $276 | 0.00% | −295−84.3% | Reduced |
| Headlands Technologies LLC | 7 | $35 | 0.00% | +7 | New |
| Royal Bank of Canada | 76 | $0 | 0.00% | +76 | New |
| AlphaMark Advisors, LLC | 10 | $0 | 0.00% | +10 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −490,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −30,279−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,170−100.0% | Sold out |
| GoalVest Advisory LLC | 0 | $0 | 0.00% | −1,160−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |